Takatsuki, Japan

Koyishi Kimura

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koyishi Kimura. Retrieved from https://idiyas.com/inventor/koyishi-kimura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Koyishi Kimura: Innovator in Nootropic Agents

Introduction

Koyishi Kimura is a notable inventor based in Takatsuki, Japan. His work in the field of nootropic agents has contributed significantly to both human and animal health. Through his innovative research, he has made strides in enhancing cognitive function and mental performance.

Latest Patents

Koyishi Kimura holds a patent for pyroglutamide derivatives. This patent reveals the utility of these compounds as nootropic agents. The findings indicate that these derivatives are beneficial for administration to humans and animals, thereby expanding the scope of cognitive enhancement therapies.

Career Highlights

Core to his professional achievements is his affiliation with Nippon Shinyaku Company, Ltd. This company is recognized for its commitment to advancing pharmaceutical research and development. Under Kimura's guidance and innovation, the company continues to explore new therapeutic avenues.

Collaborations

Throughout his career, Kimura has collaborated with notable colleagues, including Shoichi Chokai and Toshio Tomita. Their combined efforts have fueled innovative research projects and have led to advancements in the pharmaceutical field, particularly in the area of cognitive health.

Conclusion

Koyishi Kimura stands out as an influential inventor in the domain of nootropic agents. His contributions through the development of pyroglutamide derivatives underscore the importance of innovation in improving cognitive functions. His work at Nippon Shinyaku Company, Ltd., along with collaborative endeavors, highlights the significance of teamwork in the pursuit of scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…